21:00 , Aug 17, 2017 |  BC Innovations  |  Translation in Brief

Stopping the invasion

A team from the Netherlands Cancer Institute (NKI) has identified a network of extracellular matrix proteins that drives glioblastoma invasiveness and a master switch -- interferon regulatory factor 3 (IRF3) -- that can turn it...
23:46 , Jul 13, 2017 |  BC Week In Review  |  Company News

ASCO recommends MammaPrint to inform chemo use

In an update to its clinical practice guidelines for women with early breast cancer in the adjuvant setting, the American Society of Clinical Oncology recommended use of the MammaPrint test to identify women who need...
22:36 , Jul 10, 2017 |  BC Extra  |  Company News

ASCO recommends MammaPrint to inform chemo use

In an update to its clinical practice guidelines for women with early breast cancer in the adjuvant setting, the American Society of Clinical Oncology recommended use of the MammaPrint test to identify women who need...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Clinical News

MammaPrint: Phase III data

Agendia N.V. , Amsterdam, the Netherlands   Product: MammaPrint   Business: Diagnostic   Molecular target: Not applicable   Description: Breast cancer prognostic test using a 70-gene signature chip   Indication: Predict the risk of metastases...
23:45 , May 13, 2016 |  BC Extra  |  Company News

Management tracks

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) named James Kehoe CFO, effective June 15. Kehoe was CFO at Kraft Foods Group, now The Kraft Heinz Co. (NASDAQ:KHC). Agendia N.V. (Amsterdam, the Netherlands) named William Audeh CMO. He...
01:05 , Sep 30, 2015 |  BC Extra  |  Company News

Management tracks

Cancer diagnostics company Agendia N.V. (Amsterdam, the Netherlands) named Mark Straley CEO. Straley was president, anatomical pathology at Thermo Fisher Scientific Inc. (NYSE:TMO). Renal company Genkyotex S.A. (Plan-les-Ouates, Switzerland) said CEO Ursula Ney will resign...
01:01 , Aug 18, 2015 |  BC Extra  |  Company News

Management tracks

Molecular diagnostics play Veracyte Inc. (NASDAQ:VCYT) named Neil Barth CMO. Barth was CMO at Agendia N.V. (Amsterdam, the Netherlands). Infectious disease company Spring Bank Pharmaceuticals Inc. (Milford, Mass.) named Martin Driscoll president and CEO. He...
01:32 , Mar 25, 2015 |  BC Extra  |  Politics & Policy

CMS to emphasize clinical utility of prognostic cancer tests

At Tuesday's meeting of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) to discuss prognostic tests for cancer, CMS's James Rollins said the agency will rely more heavily on clinical utility, in addition to...
07:00 , Mar 9, 2015 |  BC Week In Review  |  Clinical News

MammaPrint FFPE regulatory update

FDA granted 510(k) clearance to Agendia’s MammaPrint FFPE test to predict the risk of breast cancer recurrence in formalin-fixed paraffin embedded (FFPE) tissue. MammaPrint FFPE uses a 70-gene signature chip to predict recurrence regardless of...
02:28 , Jan 27, 2015 |  BC Extra  |  Politics & Policy

CMS to discuss prognostic tests for cancer

CMS's Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) will meet on March 24 to discuss molecular pathology tests for the prognosis of colorectal, breast and non-small cell lung cancer (NSCLC). The committee will review...